The regulation organises into three substantive areas: (1) definitions and commencement, (2) drug and alcohol testing procedures, approvals and evidence; and (3) a rail safety investigation fee regime for large rolling stock operators. Each area uses tightly specified legal concepts that transform procedural practice into legal facts.

Definitions and commencement

• The statutory short title is Rail Safety National Law (Queensland) Regulation 2017 (s 1). The regulation commenced at the end of 30 June 2017 (s 2). Defined words referenced in the regulation are located in schedule 1 (s 3).

Drug and alcohol testing regime: approvals, methods, chain of custody and evidentiary presumptions

• Approved analyst’s laboratories: s 4 prescribes that laboratories approved by the chief executive under s 18A(1)(a) are those that count as an “analyst” for the Act’s definition of that term (the Act’s s 15 is referred to repeatedly).
• Approved devices: s 5 prescribes that devices complying with Australian Standard AS 3547 are approved for preliminary breath tests. AS 3547 is adopted as the applicable standard “as in force from time to time” and is treated as a moving reference (s 5).
• Saliva devices and laboratory tests: s 6 requires chief executive approval for devices used to conduct preliminary saliva tests; s 7 prescribes mass spectrometry as the approved laboratory test method to identify the presence of a prescribed drug in saliva analysis.
• Specimen-giving requirements: s 8 sets the procedural manner for providing breath and saliva specimens when directed by an authorised person under the Act (for breath, placing the mouth over the mouthpiece and blowing directly and continuously until told to stop; for saliva, placing or allowing a collection unit to be placed into or adjacent to the mouth and providing the specimen until told to stop). “Collection unit” is defined to mean a device approved by the chief executive under s 18A(1)(c).
• Blood specimen procedure and certificates: s 9 sets the steps a health care professional must follow when taking blood. This includes the choice of vein, the prohibition on using a cleaning substance believed to contain alcohol or ether, the quantity and labelling of specimen tubes, and the creation of a specimen certificate with specified contents (personal details, date, place and time, identifying number and the name of the authorised person who directed the specimen). The specimen certificate must accompany the specimen to the analyst and is treated as conclusive evidence of the matters stated in it, unless the contrary is proved. There is also a conclusive presumption about use of alcohol or ether in cleaning unless the health care professional testifies under oath they did so (s 9).
• Duplicate specimen handling and delivery: s 10 requires duplicate specimens given to the rail safety worker to be handled in the same manner as specimens for laboratory testing. s 11 prescribes delivery methods to a laboratory , personally or by way allowed by the IATA Dangerous Goods Regulations.
• Evidentiary certificates and supplier certificates: s 12 confirms a copy of a certificate under the Act for a saliva specimen is sufficient authority for an analyst to issue an analyst’s certificate. s 14 makes certificates purporting to be from an analyst or an approved supplier as to standard alcohol solution conclusive evidence that a sealed container with that control number contained standard alcohol solution.
• Officer authority and dispute mechanics: s 15 treats a police officer’s oral evidence that they are authorised to operate a breath analysing instrument as sufficient until the contrary is proved, and prescribes a 14 day written notice requirement to the police commissioner for anyone intending to dispute at a hearing that a particular officer was so authorised.
• General evidentiary presumptions: s 16 and s 17 provide that certificates signed by authorised persons, health care professionals, instrument operators, analysts and approved suppliers are, until contradicted, conclusive evidence of matters stated; s 18 creates a presumption that failures to comply with the regulation did not affect test results unless proved otherwise.

Approval and publication processes

• The chief executive’s approval power covers laboratories, devices for testing saliva and saliva collection units (s 18A). The chief executive must publish approvals and revocations on the department’s website, including the day the approval/revocation takes effect (s 18A(2)-(4), s 18B(2)-(4)). The chief executive must maintain a register of approvals and publish it on the department’s website (s 18C).

Rail safety investigation fee

• Definition of accredited person for fee purposes: s 19 prescribes an “accredited person” as a rolling stock operator who had effective control and management of train operations that travelled more than 1.5 million kilometres in Queensland in the previous calendar year.
• Fee period and timing: s 20 defines the period as a financial year; invoices must be issued on or before 31 July of the financial year (s 23(2)) and the payment date is 31 August of the financial year (s 22).
• Fee mechanics and CPI adjustment: s 21 sets out the variables A, B and C. A is the headline rate: $750,000 for the financial year ending 30 June 2018, and thereafter adjusted using the CPI-based formula in s 21(2). B is total kilometres by all prescribed accredited persons in the previous calendar year; C is the kilometres of the relevant accredited person. The regulation therefore operationalises an allocation of the annual rate across large operators proportionate to their kilometres in the previous calendar year (s 21). There is a non‑decreasing rule: if the CPI adjustment would reduce the rate in any financial year, the rate must not be adjusted downward (s 21(3)).
• Invoicing correction mechanism and effect: s 23 permits the chief executive to issue a corrected notice within 30 days if subsequent information reveals the invoice was incorrect. The regulation treats the amount of the original invoice as the payable amount for the financial year regardless of the correction, but directs that next year’s fee be adjusted by taking corrected amounts into account (s 23(3)-(4)). s 24 prescribes the information (previous calendar year kilometres) and the method (in writing) that an accredited person must supply to the chief executive upon request, and that the chief executive must allow at least 28 days to provide it.

Those are the main statutory building blocks used to translate testing, evidentiary and funding policy into operational rules.

Identify who bears duties, who decides, and who pays, by reference to the regulation.

Primary private-actor obligations and burdens

• Rolling stock operators with effective control and management of train operation who travelled more than 1.5 million kilometres in Queensland in the previous calendar year are prescribed as “accredited persons” for the rail safety investigation fee and therefore pay the fee under s 19. The regulation therefore concentrates financial obligations on a small set of very large operators.
• Rail safety workers who are directed by an authorised person under the Act to provide specimens are directly affected by specimen collection requirements in s 8. These workers must comply with procedural directions when providing breath and saliva specimens (mouth placement, continuous blowing, placement of collection unit and provision until told to stop).
• Health care professionals who take blood specimens have specified duties: choosing the vein, avoiding alcohol/ether cleaning substances where reasonably believed to be such, taking sufficient blood, placing it into a specimen tube, labelling the tube with an identifying number, signing a specimen certificate containing prescribed information and giving a copy to the analyst (s 9). Health care professionals are also subject to the evidentiary scheme: if they are the only person who can adduce evidence that alcohol or ether was used, their sworn evidence changes statutory presumptions (s 9(5)-(6)).

Private entities that must obtain approvals or use approved devices

• Laboratories that wish to be counted as an “analyst” for purposes of analysis or testing must be approved by the chief executive under s 18A(1)(a) (s 4). Approved laboratories are listed in the chief executive’s register (s 18C).
• Suppliers of breath analysing instruments must ensure devices comply with AS 3547 if those devices are to be used for preliminary breath tests (s 5). Saliva-testing devices and saliva collection units must be expressly approved by the chief executive (s 6 and s 18A(1)(b)-(c)).
• Entities wishing to supply standard alcohol solution used in breath analysis may be an “approved supplier” if approved by the police commissioner under Traffic Regulation 1962, s 173 and judged competent by the commissioner (s 14). Such suppliers’ certificates about standard alcohol solution are conclusive evidence as to the container contents where a control number matches (s 14).

Regulatory decision-makers and administrators

• The chief executive carries a number of decision-making and administrative functions: approving laboratories and devices (s 18A); publishing approvals and revocations to the department website (s 18A(2)-(4) and s 18B(2)-(4)); keeping and publishing the register of approvals (s 18C); determining and invoicing rail safety investigation fees and issuing corrected notices where appropriate (s 21-s 23); and requesting kilometres information from accredited persons with at least 28 days to respond (s 24).
• The police commissioner has an approval role over approved suppliers of standard alcohol solutions and is the recipient of notices challenging an officer’s authority to operate breath analysers (s 14; s 15(2)).

Actors affected by evidentiary presumptions and litigation mechanics

• Defendants and prosecution in Part 3 offences under the national law are affected by the regulation’s evidentiary provisions: specimen certificates, analyst certificates, supplier certificates, and instrument operator or police officer statements are, unless contradicted, conclusive or sufficient evidence of particular facts (s 9, s 12, s 14-s 17). A party intending to dispute a police officer’s authority to operate a breath analyser must notify the police commissioner in writing 14 days before the hearing (s 15(2)); that is a procedural hurdle imposting a notice requirement on litigants.

Those not directly named but affected by practical operation

• Any operator or service provider engaged in transporting specimens must use methods permitted by the regulation: personal delivery or carriage compliant with IATA Dangerous Goods Regulations (s 11). This affects laboratory logistics and chain of custody procedures.
• Smaller rolling stock operators , those that did not exceed the 1.5 million kilometre threshold , are not prescribed as accredited persons for the fee and therefore do not pay this particular fee (s 19). That creates a clear dividing line in financial exposure.

In short, this regulation targets very large rolling stock operators for the industry fee, places procedural obligations on rail safety workers and health care professionals for specimen collection and certification, centralises approval power in the chief executive for laboratories and saliva devices, and gives particular evidentiary advantages to certificates produced under the regulation. The identity of decision-makers and payors is explicit in the cited sections.

The regulation creates specific positive duties and confers particular evidentiary rights or presumptions that alter procedural positions in administrative and criminal contexts. Extracted duties and rights follow with the controlling section references.

Duties on instrument operators and rail safety workers

• Rail safety workers must provide breath or saliva specimens in the precise manner set out by s 8 when directed by an authorised person under the Act: for breath, place mouth over mouthpiece and blow directly and continuously until told to stop; for saliva, allow a collection unit to be placed into or adjacent to the mouth and provide the specimen until told to stop (s 8). These are mandatory procedural requirements for collecting valid preliminary specimens.

Duties on health care professionals taking blood

• When taking blood for laboratory testing, health care professionals must comply with the list in s 9: select any vein they choose, avoid use of substances reasonably believed to be or to contain alcohol or ether when cleaning the venipuncture site or instruments, take sufficient blood, place it in a specimen tube, label it with an identifying number, and sign a specimen certificate recording specified facts including the name of the authorised person who directed the specimen. They must give a copy of the specimen certificate to the analyst (s 9(1)-(3)).

Duties on analysts and instrument operators

• Analysts may rely on a copy of a certificate under the Act for a saliva specimen as sufficient authority to issue an analyst’s certificate for the specimen (s 12). Analysts and approved suppliers can sign certificates about preparation and sealing of standard alcohol solution; those certificates are conclusive evidence that a container bearing that control number contained standard alcohol solution when produced in evidence (s 14).

Duties on the chief executive and police commissioner

• The chief executive must publish approvals, revocations and the register of approvals on the department’s website, and include specified information and effective dates (s 18A(2)-(4), s 18B(2)-(4), s 18C(1)-(4)). The chief executive must invoice accredited persons for rail safety investigation fees on or before 31 July of the financial year and give them until 31 August to pay (s 23(1)-(2); s 22).
• The police commissioner is required by the regulation to be satisfied of competence before approving a supplier of standard alcohol solution under Traffic Regulation 1962 s 173; such an approved supplier’s certificate has conclusive evidentiary status (s 14).

Evidentiary rights and presumptions that benefit regulators and analysts

• The regulation establishes a range of prima facie or conclusive evidentiary presumptions that reallocate burdens of proof:
  • A specimen certificate is admissible and, unless proved otherwise, conclusive evidence of the matters it states (s 9(4)).
  • If a health care professional does not give sworn evidence that they used alcohol or ether to clean, it is conclusively presumed they did not (s 9(5)); if they do give sworn evidence they used such a substance, there is a conclusive presumption the use did not affect the analysis unless contrary is proved (s 9(6)).
  • Certificates purporting to be signed by an analyst or approved supplier regarding standard alcohol solution are conclusive evidence that a sealed container with the specified control number contained the solution (s 14(2)).
  • A police officer’s evidence that they are authorised to operate a breath analyser is sufficient until contradicted and need not be accompanied by a certificate of authority in evidence (s 15(1)).
  • Certificates by authorised persons, health care professionals or instrument operators that certify they gave necessary directions and served the required copies are, until contrary evidence is produced, conclusive of the matters stated (s 16).
  • Section 17 extends the operation of the Act’s s 52(2) to certificates made under this regulation and signed by health care professionals, analysts or approved suppliers , preserving statutory evidentiary treatment in the Act to these certificates.

Duties and rights connected to the rail safety investigation fee

• Large rolling stock operators meeting the >1.5 million km threshold have the duty to pay a fee calculated from variables defined in s 21. The chief executive must issue invoices on or before 31 July and may correct an invoice within 30 days of receiving further information (s 23). If corrected, the original invoice amount is treated as the payable amount for the financial year, although the next financial year’s fee must be adjusted in light of the corrected amount (s 23(3)-(4)). Accredited persons must provide the previous calendar year kilometres information in writing to the chief executive upon request, and the chief executive must allow at least 28 days to supply it (s 24).

Rights to information and administrative publication

• Entities have the right to see approvals and revocation notices and the approvals register on the department website, because the chief executive is required to publish that material and include effective dates and details (s 18A(2)-(4), s 18B(2)-(4), s 18C(1)-(4)). That creates transparency around which laboratories and devices are approved.

Procedural obligations for litigation challenges

• A party wishing to challenge a police officer’s authority to operate a breath analyser at hearing must give written notice to the police commissioner at least 14 days before the hearing (s 15(2)). That operates as a pre-hearing procedural requirement.

Taken together, these provisions allocate responsibilities among operational staff (health care professionals, instrument operators), technical actors (analysts, approved suppliers), industry payors (large rolling stock operators) and administrative decision-makers (chief executive, police commissioner), while conferring substantial evidentiary weight on certificates and procedural compliance. The regulation therefore alters the practical balance of duties and proofs in both administrative compliance and Part 3 offence prosecutions under the national law.

The regulation itself contains no distinct schedule of monetary fines or criminal penalties; rather it specifies procedural obligations, evidentiary presumptions, publication duties and fee payment mechanisms that support enforcement under the Rail Safety National Law (the Act) and Part 3 offences referenced in the regulation. The enforcement picture in the regulation consists of the following practical mechanisms and procedural levers.

Evidentiary presumptions that assist enforcement of Part 3 offences

• Certificates and specimen certificates are given strong evidentiary status. For example, a specimen certificate signed by a health care professional is admissible and, unless the contrary is proved, conclusive evidence of the matters stated (s 9(4)). Certificates by analysts and approved suppliers about standard alcohol solution are, when produced, conclusive evidence of the container contents (s 14(2)). Certificates by authorised persons, health care professionals or instrument operators certifying they gave necessary directions and distributed required copies are conclusive until contradicted (s 16). Section 17 brings the Act’s s 52(2) evidentiary regime to bear on certificates made under the regulation and signed by certain professionals. These conclusive or prima facie evidentiary rules reduce the need for prosecutors or regulators to call additional witnesses or produce other proof about the steps in specimen handling, shifting the strategic landscape for prosecutions and regulatory enforcement under the Act.

Procedural hurdles for defendants or respondents

• The regulation creates specific notice requirements that affect courtroom contestation. A person who intends to dispute at a hearing that a police officer was authorised to operate a breath analysing instrument must give the police commissioner written notice 14 days before the hearing (s 15(2)). That is a pre-hearing administrative step that, if not complied with, could constrain a defendant’s ability to dispute authority evidence.

Chain-of-custody and transport constraints as enforcement support

• The regulation requires particular treatment of specimens (labelling, specimen certificates, duplicate specimen handling) and prescribes delivery methods to a laboratory (personal delivery or by a method permitted under the IATA Dangerous Goods Regulations) (s 9, s 10, s 11). Proper labelling and use of acceptable transport routes make it easier for prosecutors or regulators to rely on chain-of-custody documentation; conversely, non-compliance is presumed not to have affected results unless the contrary is proved (s 18), which raises the evidentiary hurdle for defendants.

Administrative enforcement via invoices and payment deadlines

• The chief executive must give invoices for the rail safety investigation fee on or before 31 July and the payment date is 31 August (s 23(2); s 22). While the regulation does not specify late-payment penalties in the text supplied, the invoice-and-pay structure is an enforcement locus: failure to pay could be pursued under the Act’s enforcement mechanisms or under general revenue recovery mechanisms applicable to the department. The regulation also sets the mechanism by which fees are allocated and corrected (s 23); the chief executive can issue corrected notices within 30 days of receiving further information (s 23(3)), and the original invoice amount is taken to be the fee payable for that year (s 23(4)(a)).

Revocation and removal powers affecting suppliers and laboratories

• The chief executive may revoke approvals of laboratories and devices and must publish the revocation and its effective date on the department website (s 18B). Revocation withdraws the regulatory authority to be treated as an approved laboratory or device and so can have immediate practical enforcement effects on the ability of a party to rely on a given laboratory or device for compliance and evidentiary purposes.

Presumptions relating to cleaning agents and blood specimens

• Section 9 contains a conclusive presumption that no alcohol- or ether-containing cleaning substance was used in cleaning the venipuncture site or instruments unless the health care professional gives evidence on oath that they did so (s 9(5)). If the professional gives such sworn evidence, it is conclusively presumed the use did not affect the analysis unless the contrary is proved (s 9(6)). These presumptions affect the types of forensic challenges a defendant might bring and the proof they must marshal.

What the regulation does not itself do

• The regulation does not set out specific monetary fines or criminal penalties in its text; those remain the province of the Act and its Part 3 offence provisions. Nor does it specify administrative penalty regimes (for example infringement notices) in the supplied text. Enforcement therefore largely relies on prosecutorial mechanisms under the national law and administrative capacity (invoicing, publishing approvals, revoking approvals) on the part of the chief executive and police commissioner.

In practice the regulation structures enforcement by making certificates and documentary steps decisive and by centralising approval powers. That reduces the number of contested factual issues that require forensic proof in enforcement proceedings, while imposing procedural and documentary duties whose breach must be affirmatively proved to have produced prejudice to negate the evidentiary presumptions created by the regulation.

This regulation functions as an instrument subordinate to the Rail Safety National Law (Queensland) Act and interacts with other legislative instruments and standards referred to in the text. The most salient statutory interlocks follow.

Interaction with the Rail Safety National Law (the Act)

• The regulation explicitly implements definitions and procedures required by the Act. Many provisions state “For section 15 of the Act, definition ...” or “For section 34 of the Act ...” and similar references (for example s 4-s 8, s 11-s 17). It therefore operates as a detailed implementation regulation translating the Act’s higher‑level definitions and powers into operational practice and procedures. The regulation also invokes the Act’s Part 3 offences in evidentiary presumptions (s 9(5) refers to “a proceeding for an offence against the national law, part 3”).

Interaction with Australian Standards and external technical regimes

• The regulation adopts Australian Standard AS 3547 for breath analysing instruments, and it does so as a moving standard “as in force from time to time” (s 5). That means the regulation’s technical standard is anchored to a standard external to the statute, and updates to AS 3547 will be incorporated without separate amendment to the regulation.
• Concerning transport of dangerous goods (specimens), the regulation permits delivery to a laboratory personally or “a way provided for under the International Air Transport Association Dangerous Goods Regulations” (s 11). This links specimen transport regulation to international dangerous goods carriage rules, requiring conformity of lab specimen logistics with IATA standards.

Interaction with the Traffic Regulation 1962

• Section 14 defines “approved supplier” by reference to the police commissioner being satisfied of competence and having approved the entity under Traffic Regulation 1962, s 173, to perform the activities of preparing and certifying standard alcohol solution. That cross-reference imports an approval mechanism and competence standard from the Traffic Regulation into the evidentiary regime of the rail safety context.

Interaction with administrative law principles and general evidence law

• The regulation creates statutory presumptions and conclusive evidence rules (s 9, s 14, s 16, s 17). Those statutory rules will operate alongside general rules of evidence and administrative law governing admissibility and weight of documents and statements. Section 17 explicitly applies the Act’s s 52(2) regime to certificates made under the regulation and signed by specified persons, tying the regulation’s evidentiary rules back to the Act’s statutory evidence architecture.

Relationship to criminal procedure and pre-hearing practice

• Section 15 requires written notice to the police commissioner 14 days before a hearing where a person intends to dispute a police officer’s authority to operate a breath analysing instrument. That creates a procedural interlock between criminal defence rights and administrative processes administered by the police commissioner. The regulation therefore inserts an administrative notice requirement into the pre-hearing strategy for challenging operator authority.

Fiscal and administrative interaction

• The rail safety investigation fee regime sits within the Act as a fee raising mechanism. The regulation supplies the mechanism for identifying payors (s 19), calculating the rate and apportionment using kilometres and CPI (s 21), and invoicing and payments (s 22-s 24). Payment and invoicing are administrative acts by the chief executive but they will interact with general public finance, debt recovery and possibly taxation or appropriation frameworks relevant to the department administering the national law.

Limits on the regulation’s scope

• The regulation does not purport to create separate criminal offences or to displace the Act’s general offences; it provides procedural and evidential rules intended to support enforcement under the Act. Also, the regulation references and depends on other instruments , AS 3547, IATA Dangerous Goods Regulations, Traffic Regulation 1962 s 173 , so compliance necessarily requires interaction with those regimes.

In summary, the regulation is tightly interwoven with the Act and with technical and regulatory standards external to the Act. It imports external standards by reference, creates procedural steps that link to criminal and administrative hearings, and relies on other instruments for supplier approval and transport of specimens.

The supplied regulation text contains internal amendment annotations showing the regulation has been amended on multiple occasions. The notable amendment entries and insets in the text are reproduced below, citing the sections marked with amendment notes.

Commencement and initial enactment

• The regulation is the Rail Safety National Law (Queensland) Regulation 2017 and commenced at the end of 30 June 2017 (s 1-s 2). The passage of the instrument in 2017 is the foundational enactment.

Amendments recorded in the text

• Section 5 contains amendment annotations: “s 5 amd 2022 SL No. 41 s 4; 2025 SL No. 160 s 6” and the section appears twice with two subsections reflecting a previous and current drafting form. That indicates s 5 was amended in 2022 by Subordinate Legislation (SL) No. 41, s 4, and again in 2025 by SL No. 160, s 6. The section also states that AS 3547 is taken “as in force from time to time” which may have been added in the 2025 amendment.
• Several sections have “sub 2025 SL No. 160” amendment markers. For example, s 4 and s 6 include “s 4 sub 2025 SL No. 160 s 5” and “s 6 sub 2025 SL No. 160 s 7” respectively, indicating that in 2025 SL No. 160 substituted the text of those sections.
• Sections introduced or inserted by the 2025 SL No. 160 amendments include s 18A, s 18B and s 18C, each annotated “ins 2025 SL No. 160 s 9”. Those sections establish the chief executive’s approval, revocation and register powers for laboratories and particular devices, and therefore represent a structural amendment to the regulation’s approval regime enacted in 2025.
• Section 8 also contains amendment markers: “s 8 amd 2024 SL No. 145 s 3; 2025 SL No. 160 s 8” showing it was amended in 2024 and again in 2025.
• Section 7 has an annotation “s 7 sub 2025 SL No. 160 s 7” showing substitution in 2025. Section 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 also display amendment markers , many “ins 2025 SL No. 160 s 9” or “sub 2025 SL No. 160 s 9”, indicating the 2025 subordinate legislation made more extensive changes across the regulation.

Interpretation of amendment annotations

• The annotations indicate the regulation has been subject to staged amendments, including in 2022, 2024 and a significant set of insertions and substitutions in 2025 under SL No. 160. The 2025 changes in particular introduced s 18A-s 18C (approval, revocation, register), and substituted provisions involving devices, laboratories and the evidentiary and procedural framework.
• The amendment annotations also show the ongoing incorporation-by-reference approach to standards (for instance the AS 3547 provision in s 5 with 2022 and 2025 amendments), suggesting a pattern of technical updates linked to evolving standards and device types.

Practical effect of the amendment history

• The 2025 insertions centring approval, revocation and register functions placed formal administrative control in the chief executive and created publication obligations, illustrating a regulatory trend toward formalising approval and transparency mechanisms. The 2024 amendment to specimen provision procedures (s 8) and the 2022 amendment to the breath device standard indicate stepwise technical adjustments.
• Because the text includes the amendment annotations, the current operative regulation includes the cumulative amendments to date and the inserted sections. Users must therefore rely on the consolidated text (as provided) and be alert to subsequent subordinate legislation that could further adjust standards, approvals or fee mechanics.

In short, the regulation has been amended more than once since 2017, with a notable package of changes in 2025 that added a chief executive-centred approval, revocation and register architecture and substituted or updated multiple examination and device-related provisions. The amendment markers in the supplied text are the sole source for this summary.

The supplied regulation text does not refer to any judicial decisions, cases, or litigation outcomes. There are no cases named in the regulation itself. That said, several provisions are likely to shape litigation strategy and administrative challenges because they reallocate evidentiary burdens and create statutory presumptions. The litigation-relevant features in the text are as follows.

Evidentiary presumptions and conclusive certificates

• The regulation gives certificates and specimen certificates high evidentiary weight: specimen certificates signed by a health care professional are admissible and “unless the contrary is proved, conclusive evidence” of the matters stated (s 9(4)); certificates by analysts or approved suppliers about sealed standard alcohol solution are, when produced in evidence, conclusive evidence that the container contained standard alcohol solution (s 14(2)); certificates by authorised persons, health care professionals and instrument operators are conclusive evidence of matters stated if the signatory certifies they gave necessary directions and delivered required copies (s 16). Section 17 applies the Act’s s 52(2) to certificates under the regulation. These statutory rules shift evidentiary burdens to parties seeking to rebut certificates, and will be focal in litigation over Part 3 offences. In practice, defence counsel will be required to produce positive evidence that contradicts those certificates to overcome the conclusive presumption.

Presumptions on cleaning agents used in blood collection

• Section 9 contains specific conclusive presumptions concerning whether alcohol or ether was used to clean the venipuncture site or instruments. If the health care professional does not give sworn evidence that such a substance was used, the regulation conclusively presumes none was used (s 9(5)). If the health care professional does admit under oath that such a substance was used, the regulation then conclusively presumes the use did not affect the analysis unless the contrary is proved (s 9(6)). In litigation, the only source of testimonial contradiction about the use of such cleaning substances will likely be the health care professional’s sworn evidence. These provisions therefore set narrow channels through which forensic contamination arguments may be advanced.

Procedural notice requirement to challenge police officer authority

• Section 15(2) requires that a person intending to challenge at hearing a police officer’s authority to operate a breath analyser must give written notice to the police commissioner at least 14 days before the hearing. Litigation practitioners must therefore incorporate this notice requirement into pre-hearing strategy or risk procedural disadvantage. The provision implies hearings may admit the officer’s oral assertion of authority as sufficient evidence unless the requirement is met.

Presumptions about regulation non-compliance

• Section 18 presumes that failure to comply with a provision of the regulation did not affect the analysis of breath or saliva, or the result of a laboratory test of saliva or blood, unless the failure is proved to have substantially affected the analysis or result. That presumption raises the evidential threshold for litigants aiming to exclude or challenge test results on procedural compliance grounds.

Implications for likely litigation themes

• Given the conclusive character of many certificates and the presumptions about compliance, litigation is likely to concentrate on: (a) the authenticity and correctness of certificates and identifying numbers on specimen tubes; (b) whether the specific procedural steps required by the regulation were actually followed, and if not whether the non-compliance substantially affected the result (s 18); (c) witness testimony from health care professionals to rebut the conclusive presumptions about cleaning agents (s 9); and (d) procedural compliance with the 14 day notice rule for disputes under s 15(2). Defence strategies must therefore focus on generating direct evidence to counter statutory presumptions.

Absence of reported cases in the text

• Because no judicial decisions are cited in the regulation, this section cannot catalogue precedents that interpret or apply the regulation. Practitioners should therefore monitor case law arising from prosecutions under the national law’s Part 3 offences to see how courts treat these statutory presumptions and certificates. Until such cases are reported and considered, the regulation’s statutory presumptions and notice requirements will govern the litigation posture in their entirety.

In short, while the regulation does not include or reference litigation history, its evidentiary design and procedural notice rules will materially influence litigation tactics and the allocation of proof in enforcement proceedings under the national law.

This regulation contains several technical and procedural traps that may catch parties who do not read the text closely. The following are specific operational pitfalls with section citations and explanation of the mechanics that create the risks.

1. Strict specimen-provision form requirements (s 8)

• For breath specimens, the regulation requires the worker to place their mouth over the mouthpiece and blow directly and continuously (without escape of breath otherwise) until told to stop (s 8(1)). For saliva, a collection unit must be placed into or adjacent to the mouth and the worker provide the specimen until told to stop (s 8(2)). Failure to adhere strictly to this wording may be argued to cause non-compliance. However, s 18 then creates a presumption that failure to comply did not affect the analysis unless proved otherwise, so tactical arguments must show substantial impact.

2. The health care professional’s sworn evidence controls the cleaning-agent presumption (s 9(5)-(6))

• If a health care professional does not testify under oath that a substance containing alcohol or ether was used during cleaning, it is conclusively presumed none was used (s 9(5)). If they do give sworn evidence that such a substance was used, it is conclusively presumed the use did not affect the result unless the contrary is proved (s 9(6)). That turns the health care professional into a pivotal witness: their sworn testimony either eliminates a contamination line of defence or renders it harder to succeed. Defence practitioners must obtain or anticipate the health care professional’s evidence early.

3. Invoice correction mechanism locks in the original invoice amount for the current year (s 23(3)-(4))

• The chief executive may correct invoices within 30 days if new information emerges (s 23(3)). However, if such a correction occurs, the regulation treats the rail safety investigation fee payable for the financial year as the amount of the original invoice and not the corrected amount (s 23(4)(a)); the corrected amount is instead taken into account for calculating the next year’s fee (s 23(4)(b)). Practically, this means an accredited person who receives an incorrect invoice and later gets a corrected notice may nonetheless be obliged to pay the original invoiced amount for that year; any adjustment is reflected only in the following year’s fee. That can create cash-flow or fairness issues for payors and may require dispute or negotiation with the chief executive.

4. Threshold for fee liability concentrates liability on operators above 1.5 million km (s 19)

• The prescribed accredited person for the rail safety investigation fee is an operator with effective control and management of trains that travelled more than 1.5 million km in the previous calendar year (s 19). Operators at or near that threshold might consider operational or corporate structuring choices to avoid the threshold, and the regulation does not define how “effective control and management” will be applied in multi-party operational arrangements. That creates uncertainty for complex operating structures and potential gaming incentives to reduce reported kilometres.

5. Approved devices and moving standard uptake for breath devices (s 5)

• Breath analysers approved are devices that comply with AS 3547 “as in force from time to time” (s 5). That means new editions of AS 3547 will automatically become the regulatory standard without a formal regulatory amendment. Device suppliers and instrument operators must maintain awareness of AS 3547 updates and ensure continued compliance.

6. Chief executive approval, publication and revocation can change the authorised testing ecosystem with short lead times (s 18A-s 18C)

• The chief executive may approve or revoke approvals for labs and devices and must publish approvals and revocations on the department’s website with an effective date that cannot be earlier than the notice publication day (s 18A(2)-(4); s 18B(2)-(4)). Approvals take effect on the published effective date (s 18A(4)); revocations likewise take effect on the date stated (s 18B(4)). Laboratories, device suppliers and operators must therefore watch the department website for sudden changes; reliance on an approved laboratory or device may be curtailed from the effective date of revocation.

7. Chain-of-custody transport limited to personal or IATA ways (s 11)

• Section 11 narrows authorised delivery methods to “personally” or by a way provided under IATA Dangerous Goods Regulations. That limits transport options and requires laboratories and carriers to ensure compliance with IATA rules when transporting samples by air, potentially raising logistic costs and administrative burden.

8. Pre-hearing notice to challenge a police officer’s authority (s 15(2))

• A party planning to dispute a police officer’s authority to operate a breath analyser must give written notice to the police commissioner at least 14 days before the hearing (s 15(2)). Missing this deadline could foreclose a line of challenge, and the regulation does not specify consequences of non-compliance besides the evidentiary rule that the officer’s evidence is sufficient until the contrary is proved (s 15(1)).

9. Conclusive evidentiary rules reduce the number of factual disputes but raise the evidentiary bar for defendants (s 14, s 16-s 17)

• Many documents produced under the regulation have conclusive status absent contrary proof. Practitioners must plan to adduce positive contradictory evidence rather than rely on cross-examination of peripheral witnesses or generic attacks on process.

10. Information provision timing (s 24)

• When the chief executive requests the kilometres information, it must be provided in writing and within the period of at least 28 days stated in the request (s 24(2)-(3)). Failure to provide accurate, timely data risks incorrect invoicing and later correction that will not alter the fee payable for the current year (s 23(4)(a)).

These are concrete procedural and administrative risks embedded in the regulation text that affect evidence, cost and operations. They require active monitoring, precise documentary controls and early strategic planning by operators, analysts and defence counsel.

This is a practical compliance checklist broken down by actor, mapped to the controlling sections. The steps below follow directly from the regulation text and identify documents to keep, approvals to obtain or monitor, and timelines to observe.

For rolling stock operators (accredited persons subject to the fee)

• Determine whether the operator meets the accredited person threshold in the previous calendar year: effective control and management of rolling stock moving in Queensland totaling more than 1.5 million km (s 19). If so, expect invoicing and a payment obligation.
• Prepare and maintain an auditable record of kilometres travelled within Queensland by trains under your effective control and management for each calendar year. This is the metric used for fee allocation (s 21; s 24(1)).
• Respond to any request from the chief executive for kilometres information in writing and within the period of at least 28 days stated by the chief executive (s 24(2)-(3)).
• Expect an invoice from the chief executive on or before 31 July in the financial year for which the fee is payable (s 23(2)). Ensure procedures are in place to pay by 31 August (s 22).
• If you believe an invoice is incorrect, note that the chief executive may issue a corrected notice within 30 days after receiving information (s 23(3)). Be aware that the original invoice amount is taken to be the payable fee for that financial year even if corrected later (s 23(4)(a)); a corrected amount will be taken into account for next year’s calculation (s 23(4)(b)). Because of this mechanism, provide complete and accurate data proactively to avoid being locked into an incorrect invoiced amount.

For health care professionals taking blood specimens

• When taking blood for laboratory testing, comply strictly with s 9: choose any vein, avoid using any substance you reasonably believe to be or contain alcohol or ether to clean the site or equipment, take sufficient blood for the laboratory test, place the specimen in a specimen tube, put an identifying number on the tube and sign the specimen certificate containing the prescribed information (s 9(1)(a)-(f)). Provide a copy of that specimen certificate to the analyst (s 9(2)).
• Keep contemporaneous notes and clear chain-of-custody documentation, because the specimen certificate is treated as conclusive evidence of the matters stated unless proven otherwise (s 9(4)).
• Understand that if you give sworn evidence that alcohol or ether was used, the law presumes it did not affect the analysis unless contrary is proved (s 9(6)); conversely, failing to give sworn evidence leaves a conclusive presumption that none was used (s 9(5)). Prepare to give evidence as needed.

For instrument operators and authorised persons who direct and perform preliminary tests

• Ensure breath instruments conform to AS 3547 as applicable; AS 3547 is the approved standard under the regulation (s 5). Monitor the current edition of AS 3547 because the regulation adopts the standard “as in force from time to time” (s 5).
• For saliva testing, use only devices approved by the chief executive under s 18A(1)(b) (s 6). Ensure collection units used are approved under s 18A(1)(c) as “collection units” are defined by that approval (s 8(3) definition).
• When directing specimen provision, follow the precise procedural wording in s 8: for breath, instruct the worker to place the mouth over the mouthpiece and blow continuously until told to stop; for saliva, direct placement of the collection unit and instruct the worker to provide the specimen until told to stop.
• Keep signed certificates confirming that necessary directions were given and that required copies were distributed, because such certificates are conclusive evidence of matters stated unless contradicted (s 16).

For analysts and laboratories

• Seek chief executive approval under s 18A(1)(a) if you are to be treated as a laboratory for the Act’s definition of analyst (s 4; s 18A(1)(a)). Monitor the department’s approvals register and published notices on the website because approvals must be published and the register must be kept publicly (s 18A(2); s 18C).
• For saliva analysis, use mass spectrometry as the approved laboratory test method for identifying prescribed drugs (s 7).
• Ensure that when you receive specimen tubes, the specimen certificate accompanies the specimen (s 9(2)). A copy of the specimen certificate is sufficient authority for the analyst to issue an analyst’s certificate (s 9(3); s 12).
• Maintain records linking specimen identifying numbers to certificates and analysis results because certificates are conclusive evidence of the matters stated (s 9(4); s 16; s 17).

For suppliers of standard alcohol solution and breath analysers

• If preparing and supplying standard alcohol solution for breath instruments, ensure approval or competence recognition under Traffic Regulation 1962 s 173 by the police commissioner is obtained, because the regulation treats an “approved supplier” as one the police commissioner is satisfied is competent and has approved the activities (s 14(3)(a)-(b)). Maintain strict batch control and labelling with control numbers: supplier certificates about sealed containers with control numbers are conclusive evidence that the container contained standard alcohol solution (s 14(1)-(2)).
• For breath analysers, ensure devices comply with AS 3547 and retain evidence of compliance.

For the chief executive and administrative staff

• Publish approvals, details of approved laboratories and devices, and revocations on the department website. Notices must include required details and a day the approval or revocation takes effect, not earlier than the publication day, and the approval or revocation takes effect on the stated day (s 18A(2)-(4); s 18B(2)-(4)).
• Keep and publish the approvals register on the department website and include for each approval the details and effective dates and any revocation dates (s 18C).
• Issue rail safety investigation fee invoices to accredited persons on or before 31 July and include processes to accept corrected information and, if appropriate, issue corrected notices within 30 days of receiving further information (s 23(1)-(3)). Ensure systems are in place to adjust subsequent year invoicing in light of corrections (s 23(4)).

For legal teams and defence counsel

• Note the 14 day written notice requirement to the police commissioner under s 15(2) if you intend to contest an officer’s authority to operate a breath analyser at hearing. Incorporate this into pre-hearing procedure planning.
• Anticipate the statutory presumptions in s 9, s 14, s 16 and s 18 and gather positive evidence to contradict conclusive certificates where necessary. Because the regulation presumes failures to comply did not affect results unless proved otherwise (s 18), prepare forensic and expert evidence aimed at showing substantial effect if contesting results.

For logistics and transport teams

• Arrange specimen delivery either personally or under IATA Dangerous Goods Regulations when using carriers (s 11). Ensure packaging, labelling and paperwork meet IATA requirements and the laboratory’s acceptance criteria.

Monitoring and record-keeping common to all actors

• Maintain contemporaneous records and copies of specimen certificates, analyst certificates and supplier certificates. Retain emails or notices published on the department website about approvals and revocations (s 18A-s 18C).
• Stay current with AS 3547 updates and IATA Dangerous Goods Regulations. Check the department website regularly for newly published approvals or revocation notices.
• Build a reproducible audit trail for kilometres calculations and train movement metrics used for the rail safety investigation fee allocation.

Following the steps above will align day-to-day practice with the obligations, evidentiary mechanics and administrative processes set out in the regulation. Compliance relies on good documentary practice, timely responses to information requests and active monitoring of approvals and standards that the regulation either prescribes or adopts by reference.